Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,520 | 9,954 | 4,577 | 5,932 | 6,802 |
| Receivables | N/A | N/A | 122 | 245 | 440 |
| Other current assets | 700 | 0 | 151 | 94 | 83 |
| TOTAL | $11,454 | $12,463 | $4,850 | $6,271 | $7,325 |
| Non-Current Assets | |||||
| PPE Net | 215 | 223 | 249 | 254 | 303 |
| Other Non-Current Assets | 15 | 737 | 727 | 720 | 721 |
| TOTAL | $230 | $960 | $976 | $974 | $1,024 |
| Total Assets | $11,684 | $13,423 | $5,826 | $7,245 | $8,349 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 196 | 395 | 390 | 278 | 316 |
| Accrued Expenses | N/A | N/A | 27 | 117 | 127 |
| TOTAL | $196 | $395 | $417 | $395 | $443 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $196 | $395 | $417 | $395 | $443 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5 | 5 | 5 | 4 | 4 |
| Common Shares | 45 | 44 | 33 | 33 | 33 |
| Retained earnings | -71,169 | -68,941 | -56,875 | -54,945 | -53,073 |
| TOTAL | $11,488 | $13,028 | $5,409 | $6,850 | $7,906 |
| Total Liabilities And Equity | $11,684 | $13,423 | $5,826 | $7,245 | $8,349 |